A new type of immune-based therapy has recently been discovered by Viral Genetics, Inc. This biotechnology company is located in San Marino, California with a mission to discovers and develops immune-based therapies for HIV and AIDS using its thymus nuclear protein compound (TNP), which may help Lyme disease.
